Intermountain Health Care, Inc.; Revocation of U.S. License No. 0729

摘要

The Food and Drug Administration (FDA) is announcing the revocation of the establishment license (U.S. License No. 0729) and the product licenses issued to Intermountain Health Care, Inc., for the manufacture of Whole Blood, Red Blood Cells, Cryoprecipitated AHF, Plasma, and Platelets. The firm voluntarily surrendered its licenses as part of a Consent Decree of Permanent Injunction.